Why Did Peptide Sciences Shut Down? Timeline, FDA Pressure, and What It Means for the Industry
Peptide Sciences, the largest gray-market research peptide vendor in the U.S., voluntarily shut down on March 6, 2026. A breakdown of the FDA enforcement actions, pharmaceutical lawsuits, and new legislation that led to the closure.
Read Full ArticleAll News
FDA Peptide Category 1 vs Category 2: Complete List and What It Means for Access
Understanding the FDA's Category 1 and Category 2 bulk drug substance classifications for peptides, which compounds fall into each group, and how 2026 reclassification proposals could reshape compounding pharmacy access.
Are Peptides Legal for Veterinary Use? FDA, DEA, and State Regulations
A detailed look at the legal framework governing peptide use in animals, including FDA animal drug rules, extra-label use under AMDUCA, DEA scheduling considerations, and state veterinary board regulations.
Peptide Patent Wars: Novo Nordisk, Eli Lilly, and the Fight Over GLP-1 Compounding
An analysis of the ongoing legal battles between pharmaceutical giants Novo Nordisk and Eli Lilly and the compounding pharmacy industry over GLP-1 receptor agonist patents, FDA shortage declarations, and patient access.
FTC Crackdown on Peptide Advertising: Social Media, Influencer Marketing, and Compliance
How the FTC is targeting peptide advertising on social media and through influencers, and what companies need to do to stay compliant.
Australia Peptide Laws: TGA Regulations, Import Rules, and Scheduling
An analysis of Australian peptide laws covering TGA scheduling, import restrictions, and how the regulatory framework compares to the US and UK.
Are Peptides Legal in Illinois? 2026 Laws, Compounding Rules, and Telehealth
A breakdown of Illinois peptide laws in 2026, including compounding pharmacy rules, IDFPR oversight, and telehealth prescribing regulations.
FDA Peptide Naming and Labeling Requirements: How Mislabeling Leads to Enforcement
FDA peptide labeling requirements are strict and frequently enforced. Learn how mislabeled peptide products trigger warning letters, seizures, and injunctions.
Georgia Peptide Therapy Laws: What Clinics and Patients Need to Know in 2026
A breakdown of Georgia's peptide therapy laws in 2026, covering state pharmacy board rules, compounding regulations, and telehealth prescribing requirements.
Ohio Peptide Compounding Regulations and Recent Pharmacy Board Decisions
Ohio's State Board of Pharmacy has issued new guidance on peptide compounding, affecting how pharmacies can prepare and dispense peptide therapies under state law.
Colorado State Laws on Peptide Therapy Clinics and Medical Practice
Colorado's medical board and pharmacy regulations create specific requirements for peptide therapy clinics, addressing telemedicine, prescribing standards, and pharmacy operations.
FDA's Evolving Stance on GHK-Cu and Cosmetic Peptide Ingredients
The FDA's regulatory approach to cosmetic peptides like GHK-Cu demonstrates the blurry line between cosmetics and drugs, with enforcement implications for the growing peptide skincare industry.
Are Peptides Legal in Michigan? 2026 Laws and Regulations
Michigan residents seeking peptide therapy face a complex legal landscape. This guide explains current Michigan peptide laws, prescription requirements, and what's legal for consumers in 2026.
Will Compounded Semaglutide Become Illegal? Patent Law Explained
With Novo Nordisk's semaglutide patents extending into the 2030s, consumers wonder if compounded versions will be banned. We explain how patent law, FDA shortage rules, and pharmacy regulations determine compounded semaglutide's legal future.
Can Peptide Companies Legally Make Health Claims? FDA and FTC Rules
Peptide sellers frequently make bold health claims, but most violate FDA and FTC regulations. Learn what companies can legally claim about peptides and how illegal marketing puts consumers at risk.
Are Peptide Supplements FDA Approved? What Consumers Need to Know
Most peptide supplements on the market are not FDA approved, and many are illegally marketed. Learn which peptides have FDA approval, how to identify legal products, and what "FDA approved" really means.
How to Spot Fake Peptides: Legal Risks of Counterfeit Products
Counterfeit and mislabeled peptides flood the market, posing serious health and legal risks. Learn how to identify fake peptides, understand testing methods, and know your legal rights when dealing with fraudulent products.
Peptide Therapy Side Effects: Your Legal Rights If Something Goes Wrong
When peptide therapy causes harm, patients often don't know their legal options. Learn about liability for peptide therapy injuries, when you can sue, and how to protect your rights if you experience adverse reactions.
Medicare and Insurance Coverage for Peptide Therapy in 2026
Does insurance cover peptide therapy? Medicare and private insurance coverage for peptides depends on FDA approval status, medical necessity, and specific plan policies. This comprehensive guide explains when peptides are covered and how to maximize reimbursement.
FDA Peptide Regulations 2026: What You Need to Know
Comprehensive overview of FDA peptide regulations in 2026, including bulk drug substance categories, compounding restrictions, and how recent actions affect peptide access.
Telehealth Peptide Prescribing Laws: State and Federal Guide
Navigate the legal framework for telehealth peptide prescribing, including federal regulations, state-by-state requirements, and provider and patient considerations.